- Home
- BOF vs PRTG Comparison
BOF vs PRTG Comparison
Compare BOF & PRTG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BOF
- PRTG
- Stock Information
- Founded
- BOF 2017
- PRTG 1973
- Country
- BOF United States
- PRTG British Virgin Islands
- Employees
- BOF N/A
- PRTG N/A
- Industry
- BOF Packaged Foods
- PRTG Oil & Gas Production
- Sector
- BOF Consumer Staples
- PRTG Energy
- Exchange
- BOF Nasdaq
- PRTG Nasdaq
- Market Cap
- BOF 18.8M
- PRTG 17.7M
- IPO Year
- BOF 2023
- PRTG N/A
- Fundamental
- Price
- BOF $2.34
- PRTG $5.69
- Analyst Decision
- BOF
- PRTG
- Analyst Count
- BOF 0
- PRTG 0
- Target Price
- BOF N/A
- PRTG N/A
- AVG Volume (30 Days)
- BOF 83.9K
- PRTG 234.2K
- Earning Date
- BOF 08-13-2025
- PRTG 08-26-2025
- Dividend Yield
- BOF N/A
- PRTG N/A
- EPS Growth
- BOF N/A
- PRTG N/A
- EPS
- BOF N/A
- PRTG N/A
- Revenue
- BOF $8,242,843.00
- PRTG N/A
- Revenue This Year
- BOF N/A
- PRTG N/A
- Revenue Next Year
- BOF N/A
- PRTG N/A
- P/E Ratio
- BOF N/A
- PRTG N/A
- Revenue Growth
- BOF 96.47
- PRTG N/A
- 52 Week Low
- BOF $0.61
- PRTG $2.10
- 52 Week High
- BOF $4.11
- PRTG $23.01
- Technical
- Relative Strength Index (RSI)
- BOF 60.31
- PRTG 39.99
- Support Level
- BOF $1.91
- PRTG $5.24
- Resistance Level
- BOF $2.47
- PRTG $6.84
- Average True Range (ATR)
- BOF 0.15
- PRTG 0.76
- MACD
- BOF 0.03
- PRTG -0.09
- Stochastic Oscillator
- BOF 62.50
- PRTG 18.10
About BOF BranchOut Food Inc.
Branchout Food inc is engaged in the development, marketing, sale, and distribution of plant-based, dehydrated fruit and vegetable snacks and powders. Its products are currently manufactured for the company by contract manufacturers based in South America and North America that produce dehydrated fruit and vegetable products for the company using a new proprietary dehydration technology that it licenses from a third party. The Company's customers are located throughout the United States. Its current primary products are BranchOut Snacks, BranchOut Powders, and BranchOut Industrial Ingredients.
About PRTG Portage Biotech Inc.
Portage Biotech Inc is engaged in researching and developing pharmaceutical and biotech products through clinical proof of concept with an initial focus on unmet clinical needs. It is an immune-oncology company focused on overcoming immune resistance and currently managing 10 immuno-oncology assets at various development stages. Its pipeline products include IMM-60; IMM60 + Cell Therapy; (IMM60 / NY-ESO-1) + Keytruda and others.